机构:[1]AMI Key Laboratory of Chinese Medicine, Guangdong Province Academy of Chinese Medicine, Guangdong Province Hospital of Chinese Medicine, 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China.广东省中医院[2]Animal Laboratory, Southern Medical University, Guangzhou, 510515, China.[3]Animal Laboratory, 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China.[4]Lab of Chinese Materia Medica Preparation, 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China深圳市中医院深圳医学信息中心[5]Puning Hospital of Chinese Medicine, Puning, Guangdong Province, 515300, China[6]Department of Pharmaceutical Sciences, College of Pharmacy, Northeast Ohio Medical University, Rootstown, Ohio, 44272, USA
Patients with heart failure (HF) have high mortality and mobility. Xinmailong (XML) injection, a Chinese Medicine, is clinically effective in treating HF. However, the mechanism of XML's effectiveness on HF was unclear, and thus, was the target of the present study. We created a mouse model of pressure-overload-induced HF with transverse aortic constriction (TAC) surgery and compared among 4 study groups: SHAM (n = 10), TAC (n = 12), MET (metoprolol, positive drug treatment, n = 7) and XML (XML treatment, n = 14). Dynamic changes in cardiac structure and function were evaluated with echocardiography in vivo. In addition, H9C2 rat cardiomyocytes were cultured in vitro and the phosphorylation of ERK1/2, AKT, GSK3 beta and protein expression of GATA4 in nucleus were detected with Western blot experiment. The results showed that XML reduced diastolic thickness of left ventricular posterior wall, increased ejection fraction and fraction shortening, so as to inhibit HF at 2 weeks after TAC. Moreover, XML inhibited the phosphorylation of ERK1/2, AKT and GSK3 beta, subsequently inhibiting protein expression of GATA4 in nucleus (P < 0.001). Together, our data demonstrated that XML inhibited the TAC-induced HF via inactivating the ERK1/2, AKT/GSK3 beta, and GATA4 signaling pathway.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81473471, 81603429]; National Natural Science Foundation of GuangdongNational Natural Science Foundation of Guangdong Province [2014A030313402]; Guangdong Medical Research Fund [A2014271]; Specialized Research Fund for the Doctoral Program of Higher Education of ChinaSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20134425110001]; Guangdong science and Technology Foundation [2016KT1170]; Special Fund of Guangdong hospital of Chinese Medicine [YK2013B2N11, YN2014ZH01, YN2014ZHR203]; Special Fund of Guangdong Administration of Chinese Medicine [20151246]
第一作者机构:[1]AMI Key Laboratory of Chinese Medicine, Guangdong Province Academy of Chinese Medicine, Guangdong Province Hospital of Chinese Medicine, 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Qi Jianyong,Yu Juan,Tan Yafang,et al.Mechanisms of Chinese Medicine Xinmailong's protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes[J].SCIENTIFIC REPORTS.2017,7:doi:10.1038/srep42843.
APA:
Qi, Jianyong,Yu, Juan,Tan, Yafang,Chen, Renshan,Xu, Wen...&Zhang, Minzhou.(2017).Mechanisms of Chinese Medicine Xinmailong's protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes.SCIENTIFIC REPORTS,7,
MLA:
Qi, Jianyong,et al."Mechanisms of Chinese Medicine Xinmailong's protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes".SCIENTIFIC REPORTS 7.(2017)